In Pharma Marketing Analytics section of PharmProm.Ru we cover latest Pharma News, Pharmaceutical Industry articles, Pharma Journals, Pharmaceutical articles and more.
In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.
In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.
In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).
Market participants were significantly less active in early 2023 than during the rush demand in the spring of 2022. However, both inflation rates and stable household incomes now allow us to make optimistic industry growth forecasts, at least in the short term.
In February 2023, Russian manufacturers produced 100.1 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 12.6% from February 2022, -...
In 2022, the online sales or reservations of pharmaceutical products (pharmaceutical drugs and parapharmaceuticals) in Russia were 294.6 billion rubles (end-user prices, VAT included),...